5187 Allison Abbott: Italian health sector in disarray following more scandals. Nature 364 (1993), 663, with comment on page 658. From these articles: "The callousness of the malign ring of corruption centring on Italy's Ministry of Health defies belief. Former health minister Francesco De Lorenzo has apparently been colluding with drug companies for many years to fix unfair drug prices and to guarantee pharmaceuticals with no proven benefit a place in the national formulary. The shame extends to Italy's universities, where several prominent professors have been accused of accepting bribes to give the right advice. [...] The Italian pharmaceutical industry is on the brink of collapse following revelations last month of massive corruption in the registration and pricing of drugs. [...] The corruption network [...] embraced every link in the chain between the manufacture and marketing of drugs. Its extent and the cynicism of its working have shocked a nation hardened to tales of corruption." 12121 Walter Brown: L'effetto placebo. In 12108 Frigerio, 84-89. Ju''rgen Drews: Arzneimittelforschung und ethische Verpflichtung. Roche 1994. Ju''rgen Drews: The influence of drug research on concepts of disease in clinical medicine. Drugs made in Germany 30 (1987), 47-52. 13327 Martin Enserink: Are placebo-controlled drug trials ethical? Science 21 April 2000, 416. 12109 Xavier Lozoya: Farmacopea tradizionale e nuovi farmaci. In 12108 Frigerio, 3-7. 13153 Dennis Normile/Eliot Marshall: U.S., Europe, Japan look to speed up drug reviews. Science 17 March 2000, 1958-1959.